Serotype and ST-17 distribution of 651 GBS strains isolated from neonatal and non-pregnant adult invasive infections in France between 2006 and 2009
| Type of infection | Serotype no. | ST-17 no. | ||||||
| Ia | Ib | II | III | IV | V | Total | ||
| % | % | |||||||
| Neonatal meningitis | 12 (8.7) | 4 (2.9) | 0 | 119 (86.2) | 0 | 3 (2.1) | 138 (100) | 113 (81.9) |
| EOD (≤6 d) | 6 (20.7) | 0 | 0 | 23 (79.3) | 0 | 0 | 29 (100) | 23 (79.3) |
| LOD (≥7–89 d) | 6 (5.5) | 4 (3.7) | 0 | 96 (88.1) | 0 | 3 (2.7) | 109 (100) | 90 (82.6) |
| Neonatal bacteremia | 34 (20.5) | 5 (3) | 6 (3.6) | 101 (60.8) | 3 (1.8) | 17 (10.2) | 166 (100) | 89 (53.6) |
| EOD (≤6 d) | 27 (29) | 3 (3.2) | 5 (5.4) | 41 (44.1) | 2 (2.2) | 15 (16.1) | 93 (100) | 32 (34.4) |
| LOD (≥7–89 d) | 7 (9.6) | 2 (2.7) | 1 (1.4) | 60 (82.2) | 1 (1.4) | 2 (2.7) | 73 (100) | 57 (78.1) |
| Adult bacteremia | 71 (21.4) | 36 (10.3) | 37 (11.2) | 85 (25.7) | 17 (5.1) | 85 (25.7) | 331 (100) | 37 (11.2) |
| Adult meningitis | 4 (25) | 2 (12.5) | 1 (6.25) | 8 (50) | 0 | 1 (6.25) | 16 (100) | 5 (31.3) |
| Type of infection | Serotype no. | ST-17 no. | ||||||
| Ia | Ib | II | III | IV | V | Total | ||
| % | % | |||||||
| Neonatal meningitis | 12 (8.7) | 4 (2.9) | 0 | 119 (86.2) | 0 | 3 (2.1) | 138 (100) | 113 (81.9) |
| EOD (≤6 d) | 6 (20.7) | 0 | 0 | 23 (79.3) | 0 | 0 | 29 (100) | 23 (79.3) |
| LOD (≥7–89 d) | 6 (5.5) | 4 (3.7) | 0 | 96 (88.1) | 0 | 3 (2.7) | 109 (100) | 90 (82.6) |
| Neonatal bacteremia | 34 (20.5) | 5 (3) | 6 (3.6) | 101 (60.8) | 3 (1.8) | 17 (10.2) | 166 (100) | 89 (53.6) |
| EOD (≤6 d) | 27 (29) | 3 (3.2) | 5 (5.4) | 41 (44.1) | 2 (2.2) | 15 (16.1) | 93 (100) | 32 (34.4) |
| LOD (≥7–89 d) | 7 (9.6) | 2 (2.7) | 1 (1.4) | 60 (82.2) | 1 (1.4) | 2 (2.7) | 73 (100) | 57 (78.1) |
| Adult bacteremia | 71 (21.4) | 36 (10.3) | 37 (11.2) | 85 (25.7) | 17 (5.1) | 85 (25.7) | 331 (100) | 37 (11.2) |
| Adult meningitis | 4 (25) | 2 (12.5) | 1 (6.25) | 8 (50) | 0 | 1 (6.25) | 16 (100) | 5 (31.3) |